This review concluded that compared to right ventricular pacing, biventricular pacing was not associated with improved survival in people with refractory atrial fibrillation undergoing atrioventricular node ablation. However, it was associated with modest improvements in other outcomes. Considering concerns about possible missed trials, and quality of included trials, the authors' conclusions should be treated with caution.
Authors' objectives
To assess the effects of biventricular pacing, compared to right ventricular only pacing, in people with atrial fibrillation undergoing atrioventricular nodal ablation.
Searching MEDLINE (including in-process) , CINAHL, Cochrane Controlled Trials Register (CENTRAL), the Cochrane Database of Systematic Reviews, DARE and the American College of Physicians Journal Club were searched to November 2011. Search terms were reported. The bibliographies of reviews were checked. Only published studies were sought.
Study selection
Randomised controlled trials (RCTs), or subgroups of RCTs, that compared biventricular pacing to right ventricular pacing in people with atrial fibrillation undergoing atrioventricular nodal ablation were eligible for inclusion. The outcomes of interest were mortality, adverse events, echocardiographic data (such as ejection fraction) and functional outcomes (New York Heart Association functional class, exercise stress duration, quality of life.
In the included studies between 38 and 73% were men, and mean ages ranged from 67 to 73 years. All studies included people with persistent or permanent atrial fibrillation. Between 10 and 42% had coronary artery disease. Mean left ventricular ejection fraction ranged from 37 to 57, and where reported, mean New York Heart Association class from 2 to 2.6. Three studies included people with left ventricular systolic dysfunction. Biventricular pacing mode was dualchamber and rate-responsive.
The authors did not state how many reviewers selected studies for inclusion.
Assessment of study quality
Quality was assessed using the Jadad scale.
Two reviewers independently assessed quality. Disagreements were resolved by consensus.
Data extraction
Data were extracted to calculate odds ratio (OR) and 95% confidence intervals (CI) for dichotomous data; mean differences and 95% confidence intervals were calculated for continuous data. For continuous data where only baseline and follow-up data were reported, change and standard deviation were calculated. Data for adverse events was restricted to up to 30 days, with the exception of lead failure which could occur at any time during follow-up. For the cross over study, for mortality analyses, group size was taken as half those participating to prevent double counting.
Two reviewers independently extracted data. Disagreements were resolved by consensus.
Methods of synthesis
A random-effects model was used to calculate pooled risk ratio and 95% confidence intervals, and pooled weighted mean differences and 95% confidence intervals. Heterogeneity was assessed with Ι². Subgroup analyses investigated studies including participants with left ventricular systolic dysfunction. 
Results of the review
Four RCTs (534 participants) were included. One (56 participants) was a crossover study. Follow-up appeared to range from six to 24 months.
There was no statistically significant difference between biventricular pacing and right ventricular pacing, in all-cause mortality (Ι²=31%, four trials), procedure related adverse events (Ι²=27%, three trials) or six minute walk test duration (Ι²=0%, three trials). There was a small increase in mean left ventricular ejection fraction associated with biventricular pacing (+2.6%, 95% CI 1.7 to 3.4, Ι²=53%, four trials).
In two trials, biventricular pacing was associated with modest but statistically significant reduction in quality of life (Minnesota Living with Heart Failure Questionnaire 2.72 fewer points, 95% CI 1.45 to 3.99, Ι²=0%). A third trial reported no change in quality of life using the SF-36 Health Status Scale.
In subgroup analyses, including only those studies with baseline left ventricular systolic dysfunction, results were similar to the main analyses for all-cause mortality (Ι²=0%, three trials), and for mean left ventricular ejection fraction (Ι²=58%). These studies also reported on cardiac mortality; there was some reduction favouring biventricular pacing but this did not reach statistical significance (Ι²=0%, three trials).
